Scientific Presentations

TGFBR2 KO combined with activation-induced IL12 secretion synergize to optimize potency and safety of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer - SITC 2023 - Poster Presentation

Download the PDF file

Comprehensive Analysis of the Editing Window of TALE Base Editors - ESGCT 2023 - Poster Presentation

Download the PDF file

Intronic editing enables lineage-specific expression of therapeutics relevant for HSPC gene therapy - ESGCT 2023 - Poster presentation

Download the PDF file

Non-Viral DNA Delivery Coupled To TALEN Gene Editing Efficiently Correct The Sickle Cell Mutation In Long-Term HSCS - ESGCT 2023 - Poster Presentation

Download the PDF file

TALEN®-Edited Inducible Dual Car T-Cells Aimed at Safe and Effective Targeting Of Solid Tumors - CICON 2023 - Poster Presentation

Download the PDF file

Updated Results of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR T-cell Product, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) - EHA 2023 - Poster Presentation

Download the PDF file

UCART20x22: allogeneic dual CAR T-cells for the treatment of B-cell malignancies - ISCT 2023 - Oral Presentation

Download the PDF file

Comprehensive Analysis of the Editing Window of TALE Base Editors ISCT 2023 - Poster Presentation

Download the PDF file

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells  - ISCT 2023 - Poster Presentation

Download the PDF file

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells - ASGCT 2023 - Poster Presentation

Download the PDF file